Back and neck discomfort impact millions, often stemming from damaged spinal discs. Recent studies indicate that gene activity changes may contribute to this damage by causing spinal tissues to become abnormally hard and mineralized.
Spinal discs, positioned between vertebrae, act as cushions that absorb pressure during activities like walking, bending, lifting, or twisting. Over time or due to illness, these discs can deteriorate—a process known as intervertebral disc degeneration. This condition can lead to pain, stiffness, and limited mobility, yet currently, no medications are available to halt or reverse the damage.
Researchers from the University of Edinburgh and the University of Bristol explored this issue using zebrafish. Although their appearance differs from humans, zebrafish share many genetic and biological features, making them valuable for disease research. The focus was on a gene related to collagen IX, a protein that supports spinal disc structure, with variations previously associated with early-onset disc issues.
The scientists created zebrafish lacking a functional copy of this gene and monitored their growth. As the fish aged, their spines exhibited changes strikingly similar to human disc disease, including mineral deposits forming where they shouldn’t and eventual fusion of spinal bones. Notably, an initial warning sign emerged before mineralization: the breakdown of a supportive scaffold in the developing spine, indicating structural damage may precede calcification.
Further gene activity analysis revealed shifts in several systems, such as fat, phosphate, and vitamin A metabolism, alongside the mTOR growth pathway. These insights shed light on the mechanisms behind spinal mineralization and open avenues for possible early interventions.
In one intervention, the team tested bisphosphonates—drugs commonly used to treat osteoporosis—by inhibiting the mineral buildup in zebrafish spines. They also found that limiting food intake or using fat metabolism-altering medications reduced spinal fusion. These findings hint at potential strategies targeting phosphate processing and fat metabolism, with existing bone medications serving as starting points for future therapies.
However, these results should be interpreted cautiously. The experiments were conducted in zebrafish, and human spines are subjected to different mechanical forces and have more complex discs. Therefore, clinical trials are essential before translating these findings into human treatments.
Published in 2026 in Communications Biology, this study was led by Dr. Erika Kague of the University of Edinburgh’s Institute of Genetics and Cancer, with contributions from researchers in Edinburgh and Bristol. It is meaningful because it links a known genetic risk to specific biological changes during disc degeneration, demonstrating that some processes can be experimentally mitigated.
Despite these promising insights, zebrafish models have limitations—they don’t replicate the full complexity of the human spine. Nonetheless, this research highlights new potential pathways for drug development, aiming to address the root causes of spinal disc damage that currently lack effective treatments.
For those interested in health, exploring nutrients that fight inflammation in aging populations and key foods for healthy aging may be beneficial. Additional recent findings discuss the impact of processed foods on chronic illnesses and simple dietary adjustments to promote healthier aging after 65.